$PFE Company News Here are the best-performing stocks

New Post Public Reply Private Reply Replies (0) Message Board

Jan 13, 2015 at 1:04 PM

$PFE Company News

Here are the best-performing stocks so far in 2015 11:47 a.m. Jan. 9, 2015 - Philip van Doorn
Drug trials, upgrades boost health-care sector 11:57 a.m. Jan. 8, 2015 - Russ Britt
Younger workers are driving employers to choose urban locations 10:54 a.m. Jan. 5, 2015 - Eliot Brown
Pfizer acquires Redvax for its potential herpes vaccine 8:17 a.m. Jan. 5, 2015 - Angela Chen
Run, don’t walk, away from this year’s top performer 8:29 a.m. Dec. 31, 2014 - Mark Hulbert
Are consumers getting gouged on health care? 9:35 a.m. Dec. 30, 2014 - Russ Britt
’Tis the season for buying stocks dumped for tax reasons 9:16 a.m. Dec. 24, 2014 - Michael Brush
Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
What I learned with my 10 stock recommendations a year ago 6:00 a.m. Dec. 23, 2014 - Diana Furchtgott-Roth
How to find ‘winners’ among the worst S&P 500 stocks 5:22 p.m. Dec. 22, 2014 - Philip van Doorn
Stocking stuffers 12:27 p.m. Dec. 17, 2014 - Mark Hulbert
Boeing’s shares get lift from dividend hike, buyback 7:23 p.m. Dec. 15, 2014 - MarketWatch
U.S. stocks end choppy session lower 4:44 p.m. Dec. 15, 2014 - Barbara Kollmeyer
Pfizer, OPKO Health partner on growth-hormone treatment 1:50 p.m. Dec. 15, 2014 - Angela Chen
Opko Health's stock soars after Pfizer development agreement 8:15 a.m. Dec. 15, 2014 - Tomi Kilgore
Opko's stock jumps 8.8% premarket after Pfizer development agreement 8:07 a.m. Dec. 15, 2014 - Tomi Kilgore
Opko Health, Pfizer team up to develop Opko's GHD treatment 8:06 a.m. Dec. 15, 2014 - Tomi Kilgore
Drug makers face another $65 billion patent cliff 12:41 p.m. Dec. 10, 2014 - Russ Britt
Biogen's Alzheimer's surprise 11:24 a.m. Dec. 9, 2014 - The Trading Deck
Visa, Goldman Sachs powering Dow to 18,000 4:29 p.m. Dec. 5, 2014 - Tomi Kilgore

Dow Jones (DJIA) Today: Pfizer (PFE) Higher 12:00 p.m. Today - TheStreet.com
Bristol’s Lung Cancer Drug Aces Trial, Cheers Bulls 10:58 a.m. Today - Barrons.com
TiGenix: A Deeply Undervalued Stem Cells Company With Upcoming Catalysts 9:59 a.m. Today - Seeking Alpha
TiGenix: A Deeply Undervalued Stem Cell Company With Upcoming Catalysts 9:59 a.m. Today - Seeking Alpha
Deal Making In The Healthcare Industry 9:08 a.m. Today - Seeking Alpha
Medical Marijuana Goes to Market in Canada 3:10 a.m. Today - InvestorPlace.com
Argos Therapeutics Falls on Disappointing Phase IIb HIV Data - Analyst Blog 4:20 p.m. Jan. 12, 2015 - Zacks.com
Regeneron Can Generate 25% Upside for Investors 1:44 p.m. Jan. 12, 2015 - Barrons.com
3 Stocks Advancing The Drugs Industry 12:13 p.m. Jan. 12, 2015 - TheStreet.com
5 Biotech Stocks With Explosive Drug Pipelines 8:01 a.m. Jan. 12, 2015 - InvestorPlace.com
Dow 30 Stock Roundup: Pfizer Acquires Redvax, Microsoft Launches Affordable Internet-ready Phone - Analyst Blog 2:48 p.m. Jan. 9, 2015 - Zacks.com
3 Pharma Stocks That Soared Past Pfizer in 2014 - Analyst Blog 2:30 p.m. Jan. 9, 2015 - Zacks.com
The Bullish and Bearish Case for Pfizer in 2015 10:37 a.m. Jan. 9, 2015 - 247WallSt.com
Update: Pfizer's Palbociclib Is Closer To Approval Than Expected 8:23 p.m. Jan. 8, 2015 - Seeking Alpha
FDA clears Daiichi-Sankyo anticoagulant 7:55 p.m. Jan. 8, 2015 - Seeking Alpha
Pfizer, FDA Continue Talks on Breast-Cancer Drug 1:13 p.m. Jan. 8, 2015 - The Wall Street Journal Interactive Edition
Approval appears likely for Pfizer breast cancer candidate 12:48 p.m. Jan. 8, 2015 - Seeking Alpha
Income Ideas for 2015 11:03 a.m. Jan. 8, 2015 - Barrons.com
Dow Jones (DJIA) Today: Pfizer (PFE) Higher 11:00 a.m. Jan. 8, 2015 - TheStreet.com
5 Potential Blockbuster Drugs Set To Launch In 2015 7:02 a.m. Jan. 8, 2015 - Investors Business Daily

23andMe Announces Collaboration with Pfizer Inc. to Conduct Genetic Research Through 23andMe's Research Platform 9:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
HemoShear Announces Collaboration with Pfizer Inc. To Help Identify and Predict Drug-Induced Vascular Injury for Early Stage Compounds 8:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
Pfizer Provides Update on IBRANCE® (palbociclib) 8:31 a.m. Jan. 8, 2015 - BusinessWire - BZX
Repligen Receives Milestone Payment From Pfizer 7:30 a.m. Jan. 8, 2015 - GlobeNewswire
Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference 10:01 a.m. Jan. 6, 2015 - BusinessWire - BZX
CytomX Raises $20 Million in Series C Round Led by Pfizer Venture Investments 7:30 a.m. Jan. 6, 2015 - PR Newswire - PRF
Pfizer Acquires Redvax GmbH 7:30 a.m. Jan. 5, 2015 - BusinessWire - BZX
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Factors Moving Markets: Complementary Research on GlaxoSmithKline, Cintas, Deere, Thermo Fisher and Pfizer 9:10 a.m. Dec. 19, 2014 - PR Newswire - PRF
Pan American Fertilizer (TSX.V: PFE, Frankfurt: 6GF) Provides an Update on its Operations and Audit Filings and Announces Transfer to NEX 12:48 p.m. Dec. 18, 2014 - ACCESSWIRE
Pfizer Reports Top-Line Results From a Phase 3 Study Evaluating Pregabalin Controlled-Release Formulation as a Treatment for Patients With Postherpetic Neuralgia 8:00 a.m. Dec. 18, 2014 - BusinessWire - BZX
Pfizer Initiates Phase 2 Study of PF-06252616 in Duchenne Muscular Dystrophy 8:01 a.m. Dec. 17, 2014 - BusinessWire - BZX
Pfizer Invites Public to View and Listen to Webcast of January 27 Conference Call with Analysts 10:00 a.m. Dec. 16, 2014 - BusinessWire - BZX
Meningococcal Meningitis Survivor and TV Personality Amy Purdy and Pfizer Launch Take Action Against Meningitis 8:02 a.m. Dec. 16, 2014 - BusinessWire - BZX
Pfizer Announces Palbociclib PALOMA-1 Data Published in The Lancet Oncology 6:30 p.m. Dec. 15, 2014 - BusinessWire - BZX
Pfizer Declares First-Quarter 2015 Dividend 12:06 p.m. Dec. 15, 2014 - BusinessWire - BZX
InvestorsObserver releases comments on Pfizer, FedEx, Nike, General Mills, and DR Horton 9:31 a.m. Dec. 15, 2014 - PR Newswire - PRF
Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines 9:10 a.m. Dec. 12, 2014 - PR Newswire - PRF
Actavis Launches Generic Version of Celebrex® 9:28 a.m. Dec. 10, 2014 - PR Newswire - PRF
Pfizer and Brenda Strong Encourage Women to Change the Conversation on Sexual Health Post-Menopause 9:02 a.m. Dec. 10, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Parents Champion Meta's Online Safety Agreement

Any old-timer in the market game will tell you this: safeguarding the next generation runs deeper than just chasing profits. A recent poll by the Coalition to Empower our Future reveals something that ain’t too surprising if you’ve been paying attention. Parents all over the nation are nodding along to Meta’s new move to bolster online protections for younger folks....

Potomac Edison Eyes Rate Hike for System Overhaul

FirstEnergy's Potomac Edison Pushes for Rate Adjustment The walls are closing in on the energy sector, and Potomac Edison is seizing the moment. With their proposed $52.8 million rate adjustment, they're not only aiming to keep the lights on but to power up their entire infrastructure game. It's a gutsy move, particularly in volatile times. The Price Tag: Weighing Costs...

Local Climate Resilience Gains Urgency in the Southwest

Local Impact Means Taking Climate Change Personally If you haven't felt it yet, you will. Climate change isn't just a global headline anymore—it's a daily reality that’s reshaping life where you stand. David W. DuBois, New Mexico's top climatologist, is sounding the alarm this time on the new Net Zero Speaks episode, saying it's on us to use local climate knowledge to...

Halloween 2026: Gemmy's Animatronics Add Thrills

Halloween's New Twist with Gemmy's Animatronics Well, just when you thought Halloween couldn't get any more over the top, here comes Gemmy with their 3-foot tall animatronic characters ready to give your trick-or-treat scene that extra jolt. These aren't just any run-of-the-mill decorations. Nope, they come with a twist—an industrial-strength twist of scares and sweets...

ASU Teams Up for National Manufacturing Workforce Push

ASU's Role in Reviving American Manufacturing The Foundry School is a big hit for Arizona State University (ASU) as it joins hands with seven other top-tier universities under the U.S. Departments of State and Labor's initiative. This project is all about sculpting the future players of American manufacturing. In a scene highlighted by the Vice President and girded by...

TrailBlazer Magazine Snags a Tribune for In-House Design

Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...

GoDaddy Faces Class Action: Investor Stakes High

GoDaddy's Legal Turbulence: What's at Stake? Sometimes riding the stock wave can hit unexpected snags, and that's what's up with GoDaddy right now. They're stuck in the middle of a securities deception storm that's sending shivers down the spine of many an investor. The Class Action Lawsuit's Core Here's what you need to know: GoDaddy, with its ticker NYSE:GDDY, is...

Hyundai's Revolutionary US Steel Mill Set for 2029 Rollout

Hyundai's Major Steel Move: A Multibillion-Dollar Stake The steel industry scene in the U.S. just got a lot hotter with Hyundai's announcement of a $5.8 billion Electric Arc Furnace-based integrated steel mill in Louisiana. This game-changing project isn’t just a headline; it’s a concrete step towards beefing up the U.S. manufacturing backbone. Talk about...

PrimeBOT Shines at IFA 2026 with Innovative Awards

A New Chapter in Home Robotics In today's tech-centric world, newcomers often confuse flash with substance. But every now and then, you catch a glimpse of something that might just change how the world spins. At this year's IFA 2026, PrimeBOT didn't just dip its toes into the limelight—it cannonballed right in, drumming up some serious buzz with its PrimeBOT T1 and...

AVEX Faces Lawsuit Over IPO Missteps

By Riley Hayes Updated Sep 4, 2026 Category News Views 3

Legal Storm Brewing with AEVEX's IPO Disclosures Whatever happened to straightforward honesty in business? AEVEX Corp. (NYSE: AVEX) might have forgotten that chapter judging by fresh allegations in their midst. Investors who bought AVEX Class A common stock between April 17 and June 4, 2026, have been hit with a curveball: a looming class action lawsuit for securities...